Share this story:

Another Heritage Subsidiary Receives Updated License from Health Canada

Heritage Cannabis Holdings Corp.

Vancouver, B.C. / TheNewswire / November 15, 2018 – HERITAGE CANNABIS HOLDINGS CORPORATION (CSE: CANN)  (OTC:HERTF) (“Heritage or “Company”) is pleased to announce that its other subsidiary and Licensed Producer, CannaCure Corp. (“CannaCure”) has received its updated license in accordance with Health Canada’s Cannabis Act and Cannabis Regulations.


As previously announced on November 13, 2018 with subsidiary company PhyeinMed Inc., this new updated Standard Cultivation License, permits CannaCure to sell seeds and clones wholesale to either a provincial distribution channel or dried flower and oil to a company with a Cultivation/Processing License - Micro or Standard.


In accordance with subsection 11(5) of the Cannabis Regulations, this new license authorizes CannaCure to sell cannabis to other qualified license holders under the Cannabis Act and Cannabis Regulations, as well it allows for:

  • The sale and distribution of dried cannabis, fresh cannabis, cannabis plants and cannabis plant seeds to any qualified license holders.

    The sale and distribution of cannabis plants and cannabis plant seeds to a holder of a license for a nursery;

    The sale and distribution of cannabis plants and cannabis plant seeds, that are cannabis products to: a holder of a license for sale, or a person authorized to sell cannabis


“This has been a big week for Heritage and our subsidiaries who are preparing for production. Now with CannaCure joining PhyeinMed with an updated license, we have expanded our optionality and ability to execute on our partnership programs” states Clint Sharples, Chairman and interim CEO of Heritage “we look forward to receiving our first batch of genetics and starting to grow in Fort Erie very soon.”


About Heritage Cannabis Holdings Corp.

The Company is focused on becoming a vertically integrated cannabis provider that currently has two Health Canada approved licensed producers, through its subsidiaries PhyeinMed Inc. and CannaCure Corp. both regulated under the Cannabis Act Regulations. Heritage is focused on advancing its scale and technology footprint to compete both domestically and internationally.



“Clint Sharples”


Clint Sharples

Chairman and interim CEO


For more information contact:

Clint Sharples

Tel: 416-705-8529


The Canadian Stock Exchange does not accept responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, the results of exploration activities -- that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.